UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Nintedanib in NSCLC: evidence to date and place in therapy

Therapeutic Advances in Medical Oncology, 2016-05, Vol.8 (3), p.188-197

2016

Volltextzugriff (PDF)

The Long and Winding Road to Useful Predictive Factors for Anti-EGFR Therapy in Metastatic Colorectal Carcinoma: The KRAS/BRAF Pathway

Oncology, 2009-01, Vol.77 (Suppl 1), p.57-68

2009

Volltextzugriff (PDF)

Predicting efficacy and toxicity in the era of targeted therapy: focus on anti-EGFR and anti-VEGF molecules

Current drug metabolism, 2011-12, Vol.12 (10), p.944-955

2011

Volltextzugriff (PDF)

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

Oncotarget, 2016-04, Vol.7 (15), p.19738-19747

2016

Volltextzugriff (PDF)

Sex Steroids, Carcinogenesis, and Cancer Progression

Annals of the New York Academy of Sciences, 2004-12, Vol.1028 (1), p.233-246

2004

Volltextzugriff (PDF)

The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis

Scientific reports, 2018-09, Vol.8 (1), p.13379-10, Article 13379

2018

Volltextzugriff (PDF)

Improving the antioxidant status, fat-soluble vitamins, fatty acid composition, and lipid stability in the meat of Grass carp (Ctenopharyngodon idella Val) fed fresh ryegrass (Lolium multiflorum Lam)

Aquaculture, 2022-05, Vol.553, p.738067, Article 738067

2022

Volltextzugriff (PDF)

EGFR inhibition in NSCLC: New findings…. and opened questions?

Critical reviews in oncology/hematology, 2017-04, Vol.112, p.126-135

2017

Volltextzugriff (PDF)

Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin

Oncotarget, 2017-09, Vol.8 (42), p.71924-71932

2017

Volltextzugriff (PDF)

Clinical parameters to guide decision-making in elderly metastatic colorectal CANCER patients treated with intensive cytotoxic and anti-angiogenic therapy

Oncotarget, 2017-06, Vol.8 (23), p.37875-37883

2017

Volltextzugriff (PDF)

Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib

The oncologist (Dayton, Ohio), 2010-01, Vol.15 (1), p.85-92

2010

Volltextzugriff (PDF)

Practical Medical Oncology Textbook

1st ed. 2021., 2021

Volltextzugriff (PDF)

The resistance related to targeted therapy in malignant pleural mesothelioma: why has not the target been hit yet?

Critical reviews in oncology/hematology, 2016-11, Vol.107, p.20-32

2016

Volltextzugriff (PDF)

An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting TKI-based therapy

Expert opinion on drug safety, 2019-06, Vol.18 (6), p.485-496

2019

Volltextzugriff (PDF)

Abstract OT-31-01: A phase II study to evaluate the efficacy and safety of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer: PEMBRACA trial

Cancer research (Chicago, Ill.), 2021-02, Vol.81 (4_Supplement), p.OT-31-01-OT-31-01

2021

Volltextzugriff (PDF)

Hereditary ovarian cancer

Critical reviews in oncology/hematology, 2009-01, Vol.69 (1), p.28-44

2009

Volltextzugriff (PDF)

Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?

Cancer treatment reviews, 2010-11, Vol.36, p.S56-S61

2010

Volltextzugriff (PDF)

The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials

Critical reviews in oncology/hematology, 2017-12, Vol.120, p.227-233

2017

Volltextzugriff (PDF)

How to deal with second line dilemma in metastatic colorectal cancer? A systematic review and meta-analysis

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e15006-e15006

2019

Volltextzugriff (PDF)

Beyond evidence-based data: scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma

Oncotarget, 2016-04, Vol.7 (16), p.21259-21271

2016

Volltextzugriff (PDF)

Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects

Critical reviews in oncology/hematology, 2014-02, Vol.89 (2), p.300-313

2014

Volltextzugriff (PDF)

Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?

Oncotarget, 2016-05, Vol.7 (20), p.29321-29332

2016

Volltextzugriff (PDF)

The immunoglobulin γ marker 17 allotype and KIR/HLA genes prevent the development of chronic hepatitis B in humans

Immunology, 2020-02, Vol.159 (2), p.178-182

2020

Volltextzugriff (PDF)

The Promise of Cell Phones: From People Power to Technological Nanny

Convergence (London, England), 2008-05, Vol.14 (2), p.135-143

Rizzo, Sergio

2008

Volltextzugriff (PDF)

What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis

Critical reviews in oncology/hematology, 2015-09, Vol.95 (3), p.306-317

2015

Volltextzugriff (PDF)

26 – 50 von 504

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(432)
Mit Volltextzugriff
(433)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Nintedanib in NSCLC: evidence to date and place in therapy

The Long and Winding Road to Useful Predictive Factors for Anti-EGFR Therapy in Metastatic Colorectal Carcinoma: The KRAS/BRAF Pathway

Predicting efficacy and toxicity in the era of targeted therapy: focus on anti-EGFR and anti-VEGF molecules

PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis

Sex Steroids, Carcinogenesis, and Cancer Progression

The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis

Improving the antioxidant status, fat-soluble vitamins, fatty acid composition, and lipid stability in the meat of Grass carp (Ctenopharyngodon idella Val) fed fresh ryegrass (Lolium multiflorum Lam)

EGFR inhibition in NSCLC: New findings…. and opened questions?

Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin

Clinical parameters to guide decision-making in elderly metastatic colorectal CANCER patients treated with intensive cytotoxic and anti-angiogenic therapy

Early Skin Toxicity as a Predictive Factor for Tumor Control in Hepatocellular Carcinoma Patients Treated with Sorafenib

Practical Medical Oncology Textbook

The resistance related to targeted therapy in malignant pleural mesothelioma: why has not the target been hit yet?

An update on the conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting TKI-based therapy

Abstract OT-31-01: A phase II study to evaluate the efficacy and safety of pembrolizumab plus carboplatin in BRCA-related metastatic breast cancer: PEMBRACA trial

Hereditary ovarian cancer

Prognostic vs predictive molecular biomarkers in colorectal cancer: is KRAS and BRAF wild type status required for anti-EGFR therapy?

The effects of enzalutamide and abiraterone on skeletal related events and bone radiological progression free survival in castration resistant prostate cancer patients: An indirect comparison of randomized controlled trials

How to deal with second line dilemma in metastatic colorectal cancer? A systematic review and meta-analysis

Beyond evidence-based data: scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma

Are erlotinib and gefitinib interchangeable, opposite or complementary for non-small cell lung cancer treatment? Biological, pharmacological and clinical aspects

Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer?

The immunoglobulin γ marker 17 allotype and KIR/HLA genes prevent the development of chronic hepatitis B in humans

The Promise of Cell Phones: From People Power to Technological Nanny

What can platinum offer yet in the treatment of PS2 NSCLC patients? A systematic review and meta-analysis

Suchergebnisse filtern